Wave Life Sciences to Present at Oppenheimer 36th Annual Healthcare Life Sciences Conference

Core Insights - Wave Life Sciences Ltd. is a clinical-stage biotechnology company focused on RNA medicines to improve human health [3] - The company will participate in the Oppenheimer 36th Annual Healthcare Life Sciences Conference on February 26, 2026 [1] Company Overview - Wave Life Sciences utilizes its RNA medicines platform, PRISM®, which integrates various modalities and innovations in chemistry to address both rare and common disorders [3] - The company's pipeline includes programs targeting obesity (WVE-007), alpha-1 antitrypsin deficiency (WVE-006), and PNPLA3 I148M liver disease (WVE-008), along with clinical programs for Duchenne muscular dystrophy and Huntington's disease [3] - Wave Life Sciences aims to "Reimagine Possible" by advancing treatments that alleviate the burden of disease [3] Event Information - A live webcast of the upcoming presentation can be accessed through the "Investor Events" section on the company's website [2] - A replay of the presentation will be available for a limited time after the event [2]